Aarti Drugs Dares To Move Up.
X/2 Entry in Aarti Drugs can be taken after closing above 467 and second X/2 entry can be taken after closing above 475. Targets will be 489 and 510. Long term target in the company will be 531. Stop loss in the company can be maintained at a closing below 440. Aarti Drugs Ltd. is a manufacturer of APIs Pharma intermediates and specialty chemicals. Negative of Aarti Drugs are that they have declining net profits. Positives are such that they have Zero Promoter Pledge, Increasing Net Profit, FIIs are increasing stake and have Improving Cash Flow.
Happy Candles Investment
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.